NeuBase Therapeutics
Stock Forecast, Prediction & Price Target

NeuBase Therapeutics Financial Estimates

NeuBase Therapeutics Revenue Estimates

NeuBase Therapeutics EBITDA Estimates

NeuBase Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 9/30/2020 9/30/2021 9/30/2022 9/30/2025 9/30/2026 9/30/2027
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $10M
Low: $10M
High: $10M
avg. 0%
Avg: $6M
Low: $6M
High: $6M
avg. -40%
Avg: $152.2K
Low: $152.2K
High: $152.2K
avg. -97.46%
Net Income
 
% change YoY
$-17.26M
 
N/A
$-25.66M
 
-48.69%
$-34.23M
 
-33.37%
Avg: $-17.01M
Low: $-3.93M
High: $-3.93M
avg. 50.31%
Avg: $-20.51M
Low: $-2.55M
High: $-2.55M
avg. -20.57%
Avg: $-3.00M
Low: $-3.00M
High: $-3.00M
avg. 85.34%
EBITDA
 
% change YoY
$-16.91M
 
N/A
$-25.92M
 
-53.21%
$-32.48M
 
-25.32%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$17.6
 
N/A
-$18.8
 
-6.81%
-$21.08
 
-12.12%
Avg: -$2.42
Low: -$2.42
High: -$2.42
avg. 88.51%
Avg: -$1.57
Low: -$1.57
High: -$1.57
avg. 35.12%
Avg: -$1.85
Low: -$1.85
High: -$1.85
avg. -17.83%
Operating Expenses
 
% change YoY
$17.06M
 
N/A
$26.56M
 
55.63%
$33.31M
 
25.41%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is NeuBase Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 38.36% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -3.93M, average is -17.01M and high is -3.93M.

What is NeuBase Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of -45.82% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $10M, average is $10M and high is $10M.

What is NeuBase Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 35.26% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.42, average is -$2.42 and high is $-2.42.